Zhejiang Shouxiangu Pharmaceutical Co., Ltd. is a national high-tech enterprise located in Jinhua, Zhejiang. The company specializes in the breeding, cultivation, processing, and sales of precious Chinese medicinal materials such as Lingzhi, Tiepishihu, and saffron. Their core products include Shouxiangu brand Lingzhi spore powder (broken wall), Shouxiangu brand broken wall Lingzhi spore powder, Shouxiangu brand broken wall Lingzhi spore powder granules, Shouxiangu brand Tiepifengdou granules, and Shouxiangu brand Tiepifengdou Lingzhi extract. The company is a leader in the research and development of Lingzhi and Tiepishihu technologies, as well as the establishment of industry standards. They have developed ISO international standards for "Traditional Chinese Medicine - Lingzhi" and "Traditional Chinese Medicine - Tiepishihu," which were officially released in December 2018 and February 2019, respectively. The company is also responsible for revising the production standards for Lingzhi spore powder included in the "Zhejiang Province Traditional Chinese Medicine Processing Standards" (2015 edition) as commissioned by the Zhejiang Provincial Drug Administration. The company has been involved in the formulation of the "Chinese Medicinal Dendrobium Standard" and the "Zhejiang Province Local Standard - Pollution-Free Tiepishihu," which have been widely promoted in the industry for many years. These standards have effectively improved the level of standardized cultivation techniques for Tiepishihu in Zhejiang Province and provided technical assurance for high-yield cultivation and product quality control for farmers.
Headquarters
No. 12, Huanglong 3rd Road, Hushan Street, Wuyi County, Jinhua City, Zhejiang Province
Jinhua; Zhejiang;
Postal Code: 321200
Contact Details: Purchase the Zhejiang Shouxiangu Pharmaceutical Co., Ltd. report to view the information.
Website: http://www.sxg1909.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service